Imagion Biosystems Ltd. (AU:IBX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. has announced a significant change in the director’s interest with Robert Romeo Proulx acquiring 1,250,000 ordinary shares and 625,000 unlisted options. This acquisition highlights potential confidence in the company’s future growth prospects, capturing the attention of investors eyeing the biotech sector.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.